02-09-2026 17:41 via drugs.com

ESC: Atorvastatin Lowers Cardiovascular Event Risk in Older Adults Without Clinical CVD

WEDNESDAY, Sept. 2, 2026-- For community-dwelling older adults without clinical cardiovascular disease, atorvastatin is associated with a lower risk for major cardiovascular events, but does not improve disability-free survival, according to a...
Read more »

Pharmaceutical Industry news



Time-Restricted Eating May Help Patients With Type 1 Diabetes
Residential Context Has Larger Impact on Ovarian Cancer Survival in Black Women
ESC: Silent Atherosclerosis Present in 57.1 Percent of Adults Aged 18 to 70
Updated Recommendations Address Medications to Prevent Migraine in Adults
Recommendations Updated for Radiation Therapy in Pancreatic Cancer
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy
CDC: Buprenorphine Treatment Differs in Urban, Rural Areas
Cancer Risk ID'd for Asian American, NHPI Population
FDA Approves Lisraya for Dermatomyositis in Adults
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women
ESC: Artificial Sweetener Linked to Increased Risk for Major Cardiovascular Events
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Virtual Reality-Based Digital Defocus Vision Training May Aid Myopia in Children
Desktop versie